Why healthcare startups fail and 5 that bit the dust in 2018
Healthcare VCs provided their thoughts on why startups die, followed by a roundup of five companies that didn't survive 2018.
Healthcare VCs provided their thoughts on why startups die, followed by a roundup of five companies that didn't survive 2018.
Driver reportedly raised around $100 million and had top medical minds on its scientific advisory board, but the $3,000 price tag for its services that its cancer patients would have to pay appears to have been a flawed model to begin with.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The high cost to join the platform - which combined molecular pathology labs with a mobile app - played a role in its low sign-up numbers, CEO says.